The effect of faradarmani and lavender supplementation on the markers of doms in young girls

The present study aimed at investigating the impact of ultra-therapy [Faradarmani] and lavender supplementation on the markers of DOMS in young girls. The statistical population of the study incorporated healthy young girls who have not done regular physical activities during the last year. 48 girls were selected among volunteers as the samples of the study. They were randomly divided into four groups: ultra-therapy group (12 participants), lavender supplementation group (12 participants), ultra-therapy and lavender supplementation group (12 participants), and control group. As the first phase of the study, the whole procedure of the research was fully explained to the participants. Then, the first experimental group performed ultra-therapy exercises for four weeks (one 30-min session per day); the second experimental group consumed 60 drops of lavender tincture per day; the third experimental group both performed ultra-therapy exercises and consumed 60 drops of lavender tincture as well. However, the control group neither performed ultra-therapy exercises nor consumed any supplementation. After a month, the participants' pain feeling and creatine kinase levels were all measured in pre-test using visual analogue scale (VAS) and blood sampling, respectively. Afterwards, all the participants underwent a training program including a 5-min warm-up and 30-min running on a treadmill with a slope of -10% and at a rate equivalent to 65% of the participants' VO2 max. 24 hours and 48 hours after the training, the above-mentioned tests were administered again. Finally, the process of data analysis was done using descriptive statistics, Kolmogorov-Smirnov Test, one way ANOVA with repeated measurements, as well as Tukey's post hoc test via SPSS/21at the significance level a≤0 / 05. The study yielded the results that ultra-therapy and lavender supplementation have a significant effect on the young girls' muscle pain feeling and creatine kinase levels.